|
Herbert Y. Meltzer, M.D.
Distinguished Investigator
Dr. Herbert Y. Meltzer received his AB with honors in Chemistry from Cornell, MA in Chemistry from Harvard, and MD from Yale. Dr. Meltzer is Bixler/May/Johnson Professor of Psychiatry and Pharmacology and Director of the Psychobiology Program for Translational Research at the Vanderbilt University School of Medicine, Chairman of the International Psychopharmacology Algorithm Project, Chair of the Young Investigator Grant Review for NARSAD, and Director of the Schizophrenia Program of Centerstone Mental Health System. Dr. Meltzer has been president of the Collegium Internationale Neuropsychopharmacologicum (CINP) and the American College of Neuropsychopharmacology (ACNP). He served as editor of Psychopharmacology: The Third Generation of Progress and co-editor of the ACNP journal, Neuropsychopharmacology. He has received the Noyes Prize of the Commonwealth of Pennsylvania, the Edward J Sachar Award from Columbia University, the Lieber Prize from NARSAD, the Stanley Dean Award of the American College of Psychiatry for his research on schizophrenia, the Gold Medal Award of the Society of Biological Psychiatry, the Earl Sutherland Prize for Lifetime Achievement in Research of Vanderbilt University (2004), and the Research Prize of the American Psychiatric Association (2005). Dr. Meltzer is a member of the editorial board of numerous scientific journals. His research interests include: the psychopharmacology of schizophrenia, the mechanism of action of antipsychotic drugs, genetic factors in schizophrenia and pharmacogenomics, prevention of suicide in schizophrenia, and cognitive impairment in schizophrenia.
View Project Summary for Herbert Y. Meltzer, M.D.
View all Distinguished Investigator Project Summaries
|